By creator to www.cathlabdigest.com
Pasadena, CA – April 2020…In accordance with the CDC, practically 90% of Individuals being hospitalized with COVID-19 have an underlying medical situation. Healthcare expertise firm Circularity Healthcare, creators of D’OXYVA®, is seeking to assist these sufferers deal with these situations sooner to raised their probabilities of restoration. D’OXYVA® (deoxyhemoglobin vasodilator), the primary biotech resolution of its type, gives non-invasive, transdermal microcirculation to enhance total oxygen-rich blood move – an efficient therapy choice for quite a lot of situations together with diabetes, hypertension, cardiovascular points, COPD, and hypertension.
“D’OXYVA is aimed toward serving to thousands and thousands of individuals enhance their well being and their immune response,” says Circularity Healthcare CEO Norbert Kiss. “We’re assured this system can save lives within the struggle towards the Coronavirus by serving to restore the physique’s capabilities in individuals with underlying situations.” D’OXYVA hastens the physique’s therapeutic course of by bettering micro and macro circulation and the autonomic nervous system (ANS), detoxifying the liver and kidney, lowering irritation, and growing oxygenation and supply of vitamins. It’s the one clinically-tested, non-invasive, transportable, transdermal microcirculatory regenerative resolution system.
The over-the-counter product is meant to ease the expense and inconvenience of time-consuming physician visits by providing inexpensive and efficient administration of situations that may happen within the consolation of your personal house. “That is actually the way forward for optimized healthcare,” says Kiss. “D’OXVYA gives an superior expertise that provides a painless solution to assist individuals handle persistent well being situations and see measurable outcomes inside a matter of weeks. It is a nice strategy to save money and time by lowering the reliance on opioids and different costly medicines and workplace visits.”
In depth scientific analysis carried out over an eight-year interval has already proven unimaginable success charges. Trials have included over three dozen human scientific research together with double-blind, randomized, and placebo-controlled research at Pennsylvania State College. The corporate is now considerably increasing Section three human scientific trials working with the highest ten universities within the U.S. focusing on underlying situations particular to COVID-19 danger components comparable to oxygen-rich microcirculation in lungs, the guts, kidneys and different very important organs in addition to inflammatory markers.
The science used to create the system acquired a 2019 Nobel Prize in Physiology Drugs. D’OXYVA works by using FDA-cleared, non-toxic molecules (over-the-skin deoxyhemoglobin vasodilator) that ship a vapor of pharmaceutical-grade CO2 and water to the peripheral microcirculation. This vapor is delivered by the location of the D’OXYVA system over the thumb for a 5-minute interval. The CO2 then travels into the microcirculation of the pores and skin, the place it causes a vasodilation that results in elevated perfusion. Since its introduction in 2012, the physician-recommended, easy-to-use system has helped customers observe and regain their well being by repairing or rising new vessels and considerably bettering nerve actions within the physique.
“The very fact is that D’OXYVA will increase the effectiveness of the Microcirculatory System,” says Dr. Jim Bledsoe, PHD and Holistic Practitioner. “Rising the blood move will assist the physique enhance itself.”
D’OXYVA is at the moment out there OTC on-line at https://doxyva.com/shop/.
The corporate is actively accepting donation requests from nurses and docs to offer D’OXYVA for quick lifesaving therapy of hospital sufferers in crucial situation as a result of its Investigational Gadget Exemption (IDE) standing beneath FDA laws. For extra data, medical professionals can go to doxyva.com/covid-19? or name 626.817.6698.
# # #
About Circularity Healthcare, LLC
Circularity Healthcare, headquartered in Pasadena, California, is an rising biotech chief in proprietary circulatory well being and non-invasive pores and skin supply applied sciences. Since 2011, the corporate has been dedicated to radically altering the usual of care and bettering lives by creating, manufacturing and advertising inexpensive medical gadgets and pharmaceutical merchandise to advertise client well being and wellness. For extra data, please go to https://doxyva.com
